Trial NCT01773395

View at ClinicalTrials.gov 
Org. Study IDs: 12-217

Last trial update was posted on 2022-07-18

MeSH Interventions

Busulfan Fludarabine Methotrexate Tacrolimus

MeSH Conditions

Leukemia Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, Juvenile Myelodysplastic Syndromes

Other Conditions

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome

Stopping Reasons

Recommendation by the Data and Safety Monitoring Board due to efficacy concerns

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID